Missling Christopher U reported AVXL

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001731122-26-000036

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 6, 2026

Published

Jan 9, 2026

Ingested by INSIDER

Nov 5, 04:23 UTC

Last re-read

Nov 5, 04:23 UTC

Extracted facts

Filer

Missling Christopher U

Role

Director, President and CEO

Transaction

Grant or awardAs filed: “A”

Asset

ANAVEX LIFE SCIENCES CORP. — Stock Option (Right to Buy)

Ticker

AVXL

Shares

125.0K

Price per share

$0

Execution date (reported)

Jan 6, 2026

Owned after transaction

125.0K shares

Days from execution to publication

3

What this establishes

Missling Christopher U filed this Form 4 reporting a grant or award of AVXL on Jan 6, 2026. It became public on Jan 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, President and CEO

Missling Christopher Ucik:0001196573

Issuer

ANAVEX LIFE SCIENCES CORP.cik:0001314052

Revision history · 0

No field has changed since this record was first ingested.